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Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, with its accu-
racy and speed, is widely used for bacterial identification. The ASTA MicroIDSys system 
(ASTA, Korea) was recently developed for species identification. We compared its perfor-
mance with that of Bruker Biotyper (Bruker Daltonics, Germany). Microbes were recov-
ered from sputum, urine, and pus samples from patients admitted to a tertiary care hospi-
tal in Korea from January to April 2016. Matrix solution (α-cyano-4-hydroxycinnamic acid) 
was used, and the peptide profiles acquired from the Microflex LT (Bruker Daltonics) and 
Tinkerbell LT (ASTA) were analyzed by using their respective software. From 5,322 iso-
lates, Bruker Biotyper identified 163 species; fifty species from 4,919 isolates were identi-
fied more than 10 times, including Klebsiella pneumoniae (n=571), Acinetobacter bau-
mannii (n=436), Pseudomonas aeruginosa (n=358), Escherichia coli (n=372), Staphy-
lococcus aureus (n=511), S. epidermidis (n=444), Enterococcus faecium (n=262), E. 
faecalis (n=220), and Candida albicans (n=248). Identical results, confidence scores (≥ 
2.0 for Bruker Biotyper), and acceptable scores (≥140 for ASTA MicroIDSys) were ob-
tained for 86.1% of isolates. Of 4,267 isolates, 99.2% showed acceptable scores in both 
systems. Results from the ASTA MicroIDSys showed good agreement with those from the 
Bruker Biotyper. The ASTA MicroIDSys could reliably identify clinically important microor-
ganisms.
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Bacterial identification with automated instruments or conven-
tional methods such as biochemical reactions takes a few hours 
to days in clinical microbiology laboratories. More rapid methods 
are necessary to diagnose and treat septic patients, and better 
accuracy is necessary for classifying complicated bacterial mix-
tures. Matrix-assisted laser desorption/ionization time-of-flight 
mass spectrometry (MALDI-TOF MS) is widely used for bacterial 
identification in clinical microbiology laboratories because of its 
speed and accuracy [1-3]. 
Two in vitro diagnostic MALDI-TOF MS systems, the Bruker 
Biotyper MS (Bruker Daltonics, Bremen, Germany) and the Vi-
tek MS (bioMérieux, Marcy l’Etoile, France), have been imple-
mented in clinical microbiology laboratories worldwide and are 
routinely used for identifying bacterial and yeast isolates [4-6]. 
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Recently, a new system, the ASTA MicroIDSys system (ASTA, 
Suwon, Korea), was developed for identification of clinically im-
portant pathogenic species. The ASTA MicroIDSys system con-
sists of a linear-type MALDI-TOF MS, a database, and software 
for species identification by spectral pattern matching. The lin-
ear-type MALDI-TOF MS performs microbial MS analysis in the 
range of m/z=2,000–20,000, with a mass accuracy and resolv-
ing power of 250 ppm and 1,000, respectively. The database 
contains reference MALDI spectra for 2,604 species. The Mi-
croIDSys software employs an auto-selection algorithm for mass 
peaking of each species or strain of microorganism, in which 
the number of peaks that specifies each species is selected by 
the machine, based on pre-determined parameters, for better 
accuracy. The machine program itself selects parameters and 
masses as well as intensities of importance. In the present study, 
we compared the performance of the ASTA MicroIDSys system 
with that of the Bruker Biotyper MS system for identifying bacte-
ria and yeast in routine clinical microbiology laboratory for the 
first time.
A total of 5,322 isolates were recovered from clinical specimens 
of urine, sputum, tracheal aspirate, wounds, and pus from pa-
tients admitted to a tertiary care hospital in Korea in January-April 
2016. The specimens were inoculated in appropriate media 
such as 5% sheep blood agar, MacConkey agar, or chocolate 
agar for bacteria and Sabouraud dextrose agar for yeast, and 
then incubated for 24–48 hr at 35°C. A single bacterial colony 
from the agar was smeared onto the target plate (Bruker Dalton-
ics GmbH), the matrix solution (α-cyano-4-hydroxycinnamic acid) 
was overlaid on the spot, and the peptide profile was acquired 
from the Bruker Microflex LT system. For yeast analysis, suspi-
cious colonies were smeared directly onto the target plate and 
overlaid with 1 µL 70% formic acid (Sigma-Aldrich, St. Louis, 
MO, USA) and matrix solution. The Microflex system had the 
Biotyper software 3.1 and the MALDI Biotyper reference library 
version 5.0.0.0. The mass spectra were analyzed according to 
the manufacturer’s instructions. We used identification score 
values ≥2.0 for bacteria and yeast. After complete analysis us-
ing the Bruker Biotyper, the peptide profiles were obtained by 
using the ASTA MicroIDSys on the same target plates. All the 
mass profiles were then analyzed by using the MicroIDSys 1.0. 
The cut-off value was set at ≥140 for the ASTA MicroIDSys for 
all microorganisms. PCR and 16S rRNA gene sequencing were 
performed for isolates that showed different results from the Bru-
ker Biotyper and ASTA MicroIDSys systems.
Among the 5,322 isolates, 50 species (from 4,919 isolates) 
were isolated more than 10 times and analyzed for comparing 
the performances of the two MALDI-TOF MS systems. The re-
sults were as follows: 2,222 gram-negative bacilli, 1,926 gram-
positive cocci, 413 Candida spp., and 385 other bacteria were 
detected. The most frequently isolated bacteria were Klebsiella 
pneumoniae (n=571), followed by Acinetobacter baumannii 
(n=436), Pseudomonas aeruginosa (n=358), Escherichia coli 
(n=372), Staphylococcus aureus (n=511), S. epidermidis (n= 
444), Enterococcus faecium (n=262), E. faecalis (n=220), Co-
rynebacterium striatum (n=201), and Candida albicans (n=248).
From the 4,919 isolates studied, identical results with confi-
dence scores (≥2.0 for the Bruker Biotyper MS system) and ac-
ceptable scores (≥140 for the ASTA MicroIDSys system) were 
obtained for 4,234 (86.1%) isolates (Table 1). For the bacteria 
that are frequently isolated in clinical microbiology laboratories, 
the high agreement rates were as follows: K. pneumonia (100%), 
E. coli (98.9%), P. aeruginosa (100%), A. baumannii (99.8%), 
S. aureus (99.8%), S. epidermidis (99.8%), E. faecium (98.9%), 
and E. faecalis (99.1%). In addition, 4,841 (98.4%) isolates had 
a Bruker Biotyper score ≥1.7 and an ASTA MicroIDSys score 
≥140. Only 78 (1.6%) isolates showed discrepant results be-
tween the two systems. For these isolates, we performed 16S 
rRNA gene sequencing. However, some species in the isolates 
were not accurately identified by either of the two methods; the 
16S rRNA gene sequence similarity was very high for Enterobac-
ter and Streptococcus mitis groups [7]. 
From the observed discrepant results between the two MALDI-
TOF MS systems, we suspected that a known limitation of other 
MALDI-TOF MS systems might also be present in the ASTA Mi-
croIDSys. Microorganisms are identified by MALDI-TOF MS sys-
tems using prerecorded protein spectra that are present in the 
system library, and these spectra are mostly based on ribosomal 
proteins. Therefore, MALDI-TOF MS systems are intrinsically 
limited to differentiate closely related species or strains of Sal-
monella spp., Raoutella, Klebsiella, Enterobacter, and Citrobac-
ter [4, 8]. 
Identical results, with scores between 1.7 and 2.0 for the Bruker 
Biotyper MS system and acceptable scores ≥140 for the ASTA 
MicroIDSys system, were obtained for 581 (11.8%) isolates; 
these included 242 (58.6%) Candida spp., 205 (10.6%) gram-
positive cocci, and 82 (3.7%) gram-negative bacilli. Only two 
isolates of C. albicans showed discrepant results with an ASTA 
MicroIDSys score <140. This result suggested that the thresh-
old score for identification with the Bruker Biotyper should be 
1.7, instead of the usual 2.0, in order to compensate for the 
spectrum quality of Candida spp. In contrast, the cutoff score 
used for identification by the ASTA MicroIDSys was the typical 
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Table 1. Comparison of the results for frequently isolated bacteria from the Bruker Biotyper and ASTA MicroIDSys systems 
Species
N of isolates with identical/discrepant results
Score (Bruker): ≥2.0 Score (Bruker): 1.7≤ , <2.0
TotalScore (ASTA): Score (ASTA):
≥140 <140 ≥140 <140
Gram-negative bacilli
Acinetobacter baumannii 420/1 3 12 435/1
Acinetobacter nosocomialis 18 18/0
Burkholderia cenocepacia 13 13/0
Citrobacter freundii 16 0/1   5 21/1
Elizabethkingia meningoseptica 11   2 13/0
Enterobacter aerogenes 75 0/1   1 76/1
Enterobacter asburiae 6/9 0/1 6/10
Enterobacter cloacae 42/3 1 3/1 46/4
Enterobacter kobei 13/4 0/1 13/5
Escherichia coli 360/1 0/2   8 0/1 368/4
Haemophilus influenzae 22 1 0/1 23/1
Klebsiella oxytoca 14 1 15/0
Klebsiella pneumoniae 539 1 31 571/0
Moraxella catarrhalis 19 1 20/0
Morganella morganii 25 25/0
Proteus mirabilis 26 26/0
Providencia rettgeri 14 1 15/0
Pseudomonas aeruginosa 349 1   8 358/0
Serratia marcescens 24   1 25/0
Stenotrophomonas maltophilia 96 1 11 108/0
N of subtotal (%) 2,102/18 11/4 82/3  0/2 2,195/27
(94.6/0.8) (0.5/0.2) (3.7/0.1) (0/0.1) (98.8/1.2)
Gram-positive cocci
Enterococcus avium 12 12/0
Enterococcus faecalis 204 1/1 10/1 1 218/2
Enterococcus faecium 250/2 0/1 6 259/3
Enterococcus raffinosus     7 5 12/0
Staphylococcus aureus 501/1 1 7 510/1
Staphylococcus capitis   16 8 24/0
Staphylococcus epidermidis 356 84/1 2 443/1
Staphylococcus haemolyticus   81 0/1 42/1 125/2
Staphylococcus hominis  14 7 21/0
Staphylococcus lugdunensis   8 1/1 10/1
Streptococcus agalactiae 41 3 44/0
Streptococcus anginosus 59 1 3 63/0
Streptococcus constellatus 14 1/1 16/1
(Continued to the next page)
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Species
N of isolates with identical/discrepant results
Score (Bruker): ≥2.0 Score (Bruker): 1.7≤ , <2.0
TotalScore (ASTA): Score (ASTA):
≥140 <140 ≥140 <140
Streptococcus mitis 20/1 0/1 3/1 0/1 27/4
Streptococcus oralis 30 1/2 4/3 2/4 46/9
Streptococcus parasanguinis 21   7 28/0
Streptococcus pneumoniae 14/10 2/2 4/3 35/15
Streptococcus salivarius 23 10 33/0
N of subtotal (%) 1,671/14 6/8 205/12 5/5 1,887/39
(86.8/0.7) (0.3/0.4) (10.6/0.6) (0.3/0.3) (98.0/2.0)
Other bacteria
Clostridium difficile 30   3 1 34
Clostridium hathewayi 13   1 14
Corynebacterium amycolatum 18 18
Corynebacterium striatum 190/1 0/4   6 196/5
Lactobacillus crispatus   8 1 13 22
Neisseria flavescens 11   2 13
Rothia mucilaginosa 28 27 1 56
N of subtotal (%) 298/1 1/4 52/0 2/0 353/5
(83.2/0.3) (0.3/1.1) (14.5/0) (0.6/0) (98.6/1.4)
Candida spp.
Candida albicans 93 0/1 149/3 0/2 242/6
Candida glabrata 27 21 48
Candida krusei 11   3 1 15
Candida parapsilosis   4 19 23
Candida tropicalis 28 50 0/1 79
N of subtotal (%) 163/0 0/1 242/3 1/3 406/7
(39.5/0) (0/0.2) (58.6/0.7) (0.2/0.7) (98.3/1.7)
Total (%) 4,234/33 18/17 581/18 8/10 4,841/78
(86.1/0.7) (0.4/0.3) (11.8/0.4) (0.2/0.2) (98.4/1.6)
Table 1. Continued
140 value itself, indicating that the power to discriminate be-
tween Candida species was higher in the ASTA MicroIDSys sys-
tem than in the Bruker Biotyper system. The ASTA MicroIDSys 
MS system also showed high accuracy rates for overall identifi-
cation of bacteria and Candida spp. from isolates.
In this study, we identified clinically relevant bacteria and Can-
dida species from clinical specimens using the ASTA MicroID-
Sys system. Our findings on ASTA MicroIDSys system performance 
in the identification of bacteria and Candida species are in high 
agreement with findings from the Bruker Biotyper system. Espe-
cially for frequently isolated bacteria, such as K. pneumoniae, E. 
coli, P. aeruginosa, A. baumannii, S. aureus, S. epidermidis, E. 
faecium, and E. faecalis, high agreement rates (98.9–100%) were 
shown. In conclusion, the ASTA MicroIDSys has comparable iden-
tification capability to the Bruker Biotyper system. The ASTA Mi-
croIDSys system can reliably identify microorganisms that are 
commonly isolated in clinical microbiological laboratories.
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